Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,903 | -4,912 | -4,304 | -6,486 | -6,350 |
| Depreciation Amortization | -43 | -19 | -10 | 50 | 21 |
| Other Working Capital | 511 | 103 | -203 | -441 | 113 |
| Other Operating Activity | -2,712 | 505 | 1,122 | 1,034 | 2,084 |
| Operating Cash Flow | $-5,147 | $-4,324 | $-3,395 | $-5,843 | $-4,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,386 | -21 | -3,550 | N/A | N/A |
| PPE Investments | -18 | -27 | N/A | -53 | -94 |
| Other Investing Activity | -2,026 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,342 | $-48 | $-3,550 | $-53 | $-94 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | N/A | 5,150 |
| Debt Repayment | N/A | N/A | N/A | -28 | N/A |
| Common Stock Issued | 10,734 | 931 | 6,720 | 15 | 8,360 |
| Other Financing Activity | 0 | 0 | 0 | -173 | -183 |
| Financing Cash Flow | $10,734 | $931 | $6,720 | $-186 | $13,326 |
| Beginning Cash Position | 369 | 3,810 | 4,034 | 10,117 | 1,016 |
| End Cash Position | 7,298 | 369 | 3,810 | 4,034 | 10,117 |
| Net Cash Flow | $6,929 | $-3,440 | $-225 | $-6,083 | $9,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,147 | -4,324 | -3,395 | -5,843 | -4,132 |
| Capital Expenditure | -18 | -27 | N/A | -53 | -94 |
| Free Cash Flow | -5,165 | -4,351 | -3,395 | -5,896 | -4,226 |